A Randomised, Open-Label Preliminary Study to Assess the Effects of Etanercept 50 mg Once Weekly for 24 Weeks and Etanercept 50 mg Twice Weekly for 12 Weeks Reducing to Etanercept 50 mg Once Weekly for 12 Weeks on Nail and Skin Symptoms in Patients With Nail Psoriasis and Plaque Psoriasis. - ND
An open-label, multicentre, supplementary and extension study of Etanercept in subjects with Ankylosing Spondylitis (AS)
A Multicenter, Parallel, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of Etanercept 50 mg Once Weekly in Subjects With Moderate to Severe Plaque Psoriasis
100 项与 Wyeth Pharmaceuticals France SAS 相关的临床结果
0 项与 Wyeth Pharmaceuticals France SAS 相关的专利（医药）
100 项与 Wyeth Pharmaceuticals France SAS 相关的药物交易
100 项与 Wyeth Pharmaceuticals France SAS 相关的转化医学
